A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML von Zeidan, Amer M., Boss, Isaac, Beach, C.L., Copeland, Wilbert B., Thompson, Ethan, Fox, Brian A., Hasle, Vanessa E., Hellmann, Andrzej, Taussig, David C., Tormo, Mar, Voso, Maria Teresa, Cavenagh, James, O'Connor, Tim, Previtali, Alessandro, Rose, Shelonitda, Silverman, Lewis R.

Volltext

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes von Zeidan, Amer M., Boss, Isaac, Beach, C.L., Copeland, Wilbert B., Thompson, Ethan, Fox, Brian A., Hasle, Vanessa E., Ogasawara, Ken, Cavenagh, James, Silverman, Lewis R., Voso, Maria Teresa, Hellmann, Andrzej, Tormo, Mar, O'Connor, Tim, Previtali, Alessandro, Rose, Shelonitda, Garcia-Manero, Guillermo

Volltext

Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based... von Zeidan, Amer M., Bewersdorf, Jan Philipp, Hasle, Vanessa, Shallis, Rory M., Thompson, Ethan, de Menezes, Daniel Lopes, Rose, Shelonidta, Boss, Isaac, Halene, Stephanie, Haferlach, Torsten, Fox, Brian

Volltext

Immune and Epigenetic Landscape of TP53-mutated Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) von Zeidan, Amer M., Bewersdorf, Jan Philipp Philipp, Hasle, Vanessa, Thompson, Ethan G., Lopes de Menezes, Daniel, Rose, Shelonitda, Boss, Isaac, Fox, Brian

Volltext

Impact of Allelic State on Overall Survival in TP53-mutant Acute Myeloid Leukemia (AML) and Higher Risk Myelodysplastic Syndromes (HR-MDS) von Bewersdorf, Jan Philipp, Hasle, Vanessa, Shallis, Rory Michael, Thompson, Ethan G., Lopes de Menezes, Daniel, Rose, Shelonitda, Boss, Isaac W., Halene, Stephanie, Haferlach, Torsten, Fox, Brian, Zeidan, Amer M.

Volltext

Molecular, Epigenetic, and Immune Landscape of TP53-mutated (TP53-M) Acute Myeloid Leukemia (AML) and Higher Risk Myelodysplastic Syndromes (HR-MDS) von Bewersdorf, Jan Philipp, Hasle, Vanessa, Shallis, Rory Michael, Thompson, Ethan G., Lopes de Menezes, Daniel, Rose, Shelonitda, Boss, Isaac W., Halene, Stephanie, Haferlach, Torsten, Fox, Brian, Zeidan, Amer M.

Volltext

Integrated genetic, epigenetic, and immune landscape of mutant AML and higher risk MDS treated with azacitidine von Amer M. Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, Rory M. Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonidta Rose, Isaac Boss, Stephanie Halene, Torsten Haferlach, Brian A. Fox

Volltext

Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine von Zeidan, Amer M, Bewersdorf, Jan Philipp, Hasle, Vanessa, Shallis, Rory M, Thompson, Ethan, de Menezes, Daniel Lopes, Rose, Shelonidta, Boss, Isaac, Halene, Stephanie, Haferlach, Torsten, Fox, Brian A

Volltext

MACHINE LEARNING METHODS FOR CLASSIFYING CELLS von AIFUWA, Ivie, REISS, David, RAWSON, Keith, GUNTHER, Jon Charles, HASLE, Vanessa

Volltext bestellen

MACHINE LEARNING METHODS FOR CLASSIFYING CELLS von AIFUWA, Ivie, REISS, David, RAWSON, Keith, GUNTHER, Jon Charles, HASLE, Vanessa

Volltext bestellen

MACHINE LEARNING METHODS FOR CLASSIFYING CELLS von AIFUWA, Ivie, REISS, David, RAWSON, Keith, GUNTHER, Jon Charles, HASLE, Vanessa

Volltext bestellen

세포 분류를 위한 기계 학습 방법 von AIFUWA IVIE, GUNTHER JON CHARLES, RAWSON KEITH, REISS DAVID, HASLE VANESSA

Volltext bestellen

Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning von Gray, Vanessa E, Sitko, Katherine, Kameni, Floriane Z Ngako, Williamson, Miriam, Stephany, Jason J, Hasle, Nicholas, Fowler, Douglas M

Volltext